Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indivior plc

http://indivior.com/

Latest From Indivior plc

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

Deal Watch Business Strategies

C4XD Delisting Highlights Funding Frustration For UK Biotechs

The Manchester-based group has had enough of being undervalued in the public markets and is going private again.

Financing Business Strategies

Novo Pumps Up Heart Failure Prospects With Cardior Purchase

The Danish drugmaker is spending some of its semaglutide cash on a mid-stage RNA-based heart failure therapy developed by the German biotech.

M & A Cardiovascular

Scrip Asks…What Does 2024 Hold For Biopharma? Part 1: Business Strategy And Leadership

Global crises and a tough funding environment mean biopharma leadership teams need to work hard to survive, let alone thrive. Industry executives shared their predictions and advice on strategy for 2024.

Scrip Asks Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Indivior Inc.
    • Indivior UK Limited
    • Reckitt Benckiser Pharmaceuticals Inc. (RBP)
UsernamePublicRestriction

Register